Social Media Ideas for Beneficiary Inducement Cmp

When Free Is Permissible: OIG Allows Free Supplemental Cancer Screening Reports for Eligible Patients

On May 20, 2026, the Department of Health and Human Services Office of Inspector General (“OIG”) posted a favorable opinion, AO 26-11, regarding an arrangement in which a precision...

Unlawful Co-Pay Subsidy Scheme – Dompe US Inc. 32M FCA Settlement

HHS-OIG Issues Favorable Advisory Opinion Regarding Independent Charity Patient Assistance Program

Dompé U.S. Pays $32 Million to Resolve Co-Pay Foundation Kickback Allegations Following Voluntary Self-Disclosure

By Abdie Santiago & Jeffrey N. Wasserstein & Anne K. Walsh —

HHS-OIG Issues Favorable Advisory Opinion Regarding Healthcare Referral Service

340B Rebate Pilot — The Clock Starts Now

Cooperation, Compliance, and Consequences: Inside DOJ's $46 Million Veloxis Settlement

DOJ Rejects Petition to Allow Labs to Compensate Employed Sales Reps Using Variable Compensation Under EKRA

GLOBE and MFN Pricing: Implications for Cross-Border Drug Development and Transactions

On Oct. 2, 2026, the Centers for Medicare & Medicaid Services (CMS) published the final rule for the Global Benchmark for Efficient Drug Pricing (GLOBE) Model. GLOBE is a manda...

Drug Maker Paying $32M to Resolve Kickbacks Law Violations in California

A drug maker is paying $32 million to settle allegations it violated kickback laws by paying Medicare beneficiary co-pays to encourage the buying of its drug, Oxervate. Dompé U.S....

CMS Receives Its Exclusion Authority: What Happens Now?

The 340B Squeeze: Academic Medical Centers and Large Health Systems Have the Most to Lose

Three federal pricing changes are about to land on a single outpatient claim. The largest infusion and oncology programs will feel them first, and hardest. Most of the 340B debate...

The Villages Health System $541.5 Million Settlement: A New Frontier in Medicare Advantage Risk Adjustment Enforcement

CMS Gains Permissive Exclusion Authority: Implications for Pharma and Medical Device Companies

By Anne K. Walsh —

Compass takes CRMLS fight to court and promises to cover agent fines

Complaint alleges fines up to $2,500 for public marketing outside the MLS when clients direct it in writing

KKR Agrees to Historic $250 Million Penalty for Alleged Violations of HSR Act

DOJ, HHS Announce One-Stop Shop for Companies Voluntarily Disclosing Potential Health Care Fraud

FTC Settles First Enforcement Action Under Robinson-Patman Act in More Than 25 Years

CMS Defers $1 Billion in Medicaid Payments—and Gains New Power to Exclude Providers

Compliance Program Lessons from the Complete Health Settlement

On August 4, 2026, the United States Department of Justice (“DOJ”) on behalf of the Office of Inspector General (“OIG”) of the U.S. Department of Health and Human Services announce...

Dompe to pay $32 million over Medicare co-pay scheme for eye drug

Dompe U.S. Inc., the American subsidiary of Italy-based Dompe farmaceutici S.p.A., has agreed to pay $32 million to resolve allegations that it violated the Anti-Kickback Statute a...

Second Largest Medicare Advantage FCA Settlement of All Time

The Villages Health System LLC, a Florida-based provider deeply integrated with the retirement community of the same name, has agreed to pay $541.5 million to resolve False Claims...

FinCEN Targets $17.5 Billion in Suspected Health Care Fraud

On September 9, 2026, the U.S. Department of the Treasury announced that its Financial Crimes Enforcement Network (“FinCEN”) has identified approximately $17.5 billion in suspiciou...

OIG Clarifies That Stark Law Compliance and Fair Market Value Alone Do Not Resolve Anti-Kickback Statute Risk

In revisions released earlier this year to its General Questions Regarding Certain Fraud and Abuse Authorities, the Office of Inspector General (“OIG”) emphasized that compliance w...